Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons
Mutations in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome (RTT). Previous studies have shown that altered MeCP2 levels result in aberrant neurite outgrowth and glutamatergic synapse formation. However, causal molecular mechanisms are not well understood since MeCP2 is known to...
Main Authors: | Charanya Sampathkumar, Yuan-Ju Wu, Mayur Vadhvani, Thorsten Trimbuch, Britta Eickholt, Christian Rosenmund |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2016-10-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/19374 |
Similar Items
-
Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders
by: Xiangling Meng, et al.
Published: (2016-06-01) -
MeCP2 regulates Tet1-catalyzed demethylation, CTCF binding, and learning-dependent alternative splicing of the BDNF gene in Turtle
by: Zhaoqing Zheng, et al.
Published: (2017-06-01) -
Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice
by: Yann Ehinger, et al.
Published: (2020-02-01) -
MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?
by: Elisa eBellini, et al.
Published: (2014-08-01) -
Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations
by: Jennifer L. Larimore, et al.
Published: (2009-05-01)